Λίστα αντικειμένων
A phase II study if vedo in GvHD prevention was presented. This is of
major importance since we run the phase III vedo study.
Presenter: Prof. Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Verigou
major importance since we run the phase III vedo study.
Presenter: Prof. Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Verigou